News analysis ·
P&G beats as net income dips: reading volume and core EPS
P&G beat estimates while net income slipped. How to read GAAP versus core EPS, volume growth, segment volumes and a raised sales outlook.

Procter & Gamble reported fiscal first-quarter earnings and revenue that came in ahead of analyst forecasts, CNBC reported, and the stock gained more than 5% in morning trading. Yet the company's net income was slightly lower than a year earlier. This article looks at which lines in the report explain that mix, and how to read them on your own next time.
A beat, a small dip and a jump in the shares
The quarter covers the three months that ended Sept. 30. That is the first quarter of P&G's fiscal 2027, because the company's fiscal year does not follow the calendar year. A fiscal year is simply the 12-month period a company uses for its books.
According to CNBC, net income attributable to P&G came in at $4.73 billion ($1.97 a share), against $4.75 billion ($1.95 a share) one year before. On an adjusted basis, which leaves out restructuring costs and other items, P&G earned $2 per share. The comparison with estimates comes from a survey of analysts compiled by LSEG.
The number behind it: volume, not just EPS
Two different earnings figures sit side by side in this report. The first is the GAAP figure, the result under standard accounting rules. The second is what P&G calls core EPS, an adjusted number that removes items the company treats as one-off, such as restructuring. Analyst estimates are usually built on the adjusted figure, so a beat often refers to that line, not the GAAP one.
Notice something else. Net income dipped, yet earnings per share rose from $1.95 to $1.97. EPS divides profit by the number of shares outstanding. EPS can rise even while total profit edges down, because the number of shares can differ from a year ago. The fact sheet does not say why P&G's EPS rose, so the cause is unknown here. That is why it helps to read both lines, not only the per-share one.
For a consumer goods company, though, the number many readers watch most is volume. Volume growth measures how many more units the company sold, separate from price increases. Sales can rise just because prices went up, while fewer packs leave the shelf. Volume tells you whether shoppers are actually buying more.
P&G's overall volume grew 2.4% in the quarter, which CNBC called a strong opening to the new fiscal year. The context matters: during fiscal 2026 the company managed volume growth in only one quarter, as value-focused shoppers weakened demand and made products last longer.
Reading the segment lines
A total can hide very different stories underneath. P&G reports volume by segment, and this quarter the spread was wide.
- Fabric and home care, the unit behind Tide and Febreze, led with volume up 4.3%, helped by demand for detergent and fabric enhancers.
- Baby, feminine and family care, and beauty, each grew volume by more than 2%.
- Grooming, which includes Gillette and Venus razors, saw volume slip 0.4%.
- Health care was the weakest unit, with volume down 2.9% as demand fell for oral care such as Crest and for items like Pepto-Bismol.
Read this way, the 2.4% total leans on one large, strong segment. If fabric and home care slows in a later quarter, the total could look very different even if nothing else changes. Segment lines show where growth is concentrated, and that concentration is a risk worth noting.
What the company said
CFO Andre Schulten told CNBC the economy still looks split. Wealthier buyers are willing to trade up to pricier products, while lower-income buyers are stretching tight budgets. On the earnings call he described competition as intense and said P&G will keep tying its pricing to product innovation. In his words: "so we will price, and we will price with innovation, not jeopardizing the top-line momentum."
CEO Shailesh Jejurikar said the company expects ongoing geopolitical and economic headwinds but remains on track for its guidance. Guidance is the company's own forecast for the year. P&G kept its fiscal 2027 core EPS forecast at $6.89 to $7.11. It raised its all-in sales growth outlook to 2% to 4%, from 1% to 3% before.
Here is the detail a quick reader might miss. The higher sales outlook reflects the Thorne supplements acquisition, which closed Oct. 1. Buying a business adds its sales to the total, so part of a raised sales range can come from the deal rather than from selling more of its existing products. The unchanged EPS range is the other half of that picture.
How to check this yourself next time
You can run the same reading on any consumer company's quarterly release.
- Find both earnings lines: the GAAP net income and EPS, and the adjusted or core EPS. Check which one the analyst estimate refers to.
- Look for volume or unit growth next to sales growth, and compare it with recent quarters to see whether it is a change in trend.
- Read the guidance table and the notes beside it. If a range moved, look for a reason such as an acquisition before treating it as stronger demand.
A share price move on the day tells you how traders reacted, not whether the business is getting stronger. The report lines are where that question gets answered.
Sources
- CNBC, 22 Oct 2026
AI-drafted from the filings and reports above, then published automatically after checks that each number appears in a cited source and that no wording is copied. There was no human edit. Educational reading only, not a recommendation on any stock.